hero

Portfolio

The quality and scale of Royalty Pharma’s portfolio of pharmaceutical royalties is unparalleled in the industry. Starting in 1996, we have meticulously acquired royalty interests in many of the industry’s leading drugs by sales that address serious unmet medical needs and improve the lives of patients around the world.

Portfolio

PRODUCT MARKETER TOP INDICATIONS YEAR OF ACQUISITION STATUS AT ACQUISITION ROYALTY SELLER
Source
Relapsed or refractory acute myeloid leukemia (AML)
2020
Approved
Source
Cytomegalovirus (CMV) infection
2020
Approved
Source
Ulcerative Colitis Crohn's Disease
2020
Approved
Source
Epitheliod Sarcoma Follicular Lymphoma
2019
Pre-approval
Source
X-Linked Hypophosphatemia
2019
Approved
Source
Migraine
2019
Approved
Source
Chronic ITP
2019
Approved
Source
Breast Cancer
2018
Pre-approval
Source
Migraine
2018
Pre-approval
Source
Multiple Sclerosis
2017
Approved
Source
Breast Cancer
2016
Pre-approval
Source
Prostate Cancer
2016
Approved
Source
Cystic Fibrosis
2014
Approved
Source
Cycstic Fibrosis
2014
Approved
Source
Male Sexual Dysfunction
2014
Approved
Source
Chronic Myeloid Leukemia
2014
Pre-approval
Source
Diabetes
2014
Pre-approval
Source
Chronic Lymphocytic Leukemia Mantle Cell Lymphoma
2013
Pre-approval
Source
Multiple Sclerosis
2012
Pre-approval
Source
Rheumatoid Arthritis
2012
Approved
Source
Chronic Kidney Disease
2012
Approved
Source
Diabetes
2011
Approved
Source
Diabetes
2011
Approved
Source
Diabetes
2011
Approved
Source
Diabetes
2011
Approved
Source
Diabetes
2011
Approved
Source
Pharmacological Stress Agent for Myocardial Perfusion Imaging
2011
Approved
Source
Pompe Disease
2011
Approved
Source
Pulmonary Arterial Hypertension
2009
Approved
Source
Rotavirus Vaccine
2008
Approved
Source
Rheumatoid Arthritis Ulcerative Colitis
2007
Approved
Source
Neuropathic Pain
2007
Approved
Source
HIV
2007
Approved
Source
Rheumatoid Arthritis Ulcerative Colitis
2006
Approved
Source
HIV
2005
Approved
Source
HIV
2005
Approved
Source
HIV
2005
Approved
Source
HIV
2005
Approved
Source
HIV
2005
Approved
Source
HIV
2005
Approved
Source
HIV
2005
Approved
Source
HIV
2005
Approved
Source
Multiple Myeloma
2001
Approved
Source
Cystic Fibrosis
1999
Approved